New US FDA Adverse Event Reporting Requirements
Advocacy & Action
Important Updates from Health Canada and Environment & Climate Change Canada – December 2023
Strategy on Plastics in Quebec Consultation Published
Consultation on outcome-based licensing (GUI-0127) Management of Applications and Performance for Drug Establishment Licences
Section 71 Survey Presentation from ECCC at our recent Environmental Symposium
Animal Testing – Notice of Intent
CEPA Section 71 Survey – Cross Referenced INCI List
ECCC Commentary on VOCs Regulations at our Environmental Symposium
Volatile Organic Compound (VOC) Concentration Limits for Certain Products Regulations – Reminder
NNHPD Post-Licence Request for Products Containing Potato Starch as a Medicinal Ingredient
